BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

Countries North America

Insilico Medicine Achieves First Clinical Milestone for AI-Designed NLRP3 Inhibitor ISM8969

Insilico Medicine ("Insilico", HKEX: 3696), a clinical-stage biotechnology company powered by generative artificial intelligence (AI), announced it has ach...

June 18, 2026 | News

Halia Therapeutics Receives FDA Fast Track Designation for Ofirnoflast in Lower-Risk Myelodysplastic Syndromes

Designation follows Phase 2 data showing durable transfusion independence and multilineage hematological improvement; full results presented at EHA2026 Ha...

June 17, 2026 | News

Thermo Fisher Scientific Introduces Thermo Scientific™ M Series Centrifuges to Support Flexible and More Sustainable Laboratory Workflows

Thermo Fisher Scientific, the world leader in serving science, announced the launch of the Thermo Scientific™ M Series Centrifuges, a new generation ...

June 16, 2026 | News

Harbour BioMed's Antibody Innovation Prevails in Major Patent Clash with Amgen

The case, originally filed in 2021 by Harbour Antibodies, asserted that Amgen and Teneobio (an Amgen subsidiary) infringed patents protecting Harbour's g...

June 16, 2026 | News

SK Bioscience Licenses CDC Rotavirus Vaccine Technology to Advance Global Immunisation Efforts

SK bioscience licenses vaccine technology from the U.S. Centers for Disease Control and Prevention SK bioscience is jointly investing with t...

June 11, 2026 | News

Waters Launches Coin Cell DSC to Advance Battery Safety Testing and Thermal Analysis

Integrates heat flow, evolved gas, and electrochemical analysis in a single experiment, enabling earlier insights into thermal runaway. Unique whol...

June 11, 2026 | News

Formation Bio Doses First Participant in Phase I Trial of Lynk’s CNS-Penetrant TYK2 Inhibitor

Lynk Pharmaceuticals Co., Ltd. ("Lynk Pharmaceuticals"), a clinical-stage innovative drug development company focused on autoimmune and inflammatory diseas...

June 12, 2026 | News

XtalPi Lands $400M+ AI-Driven Drug Discovery Partnership for Metabolic GPCR Target

XtalPi (2228.HK), a leading platform in artificial intelligence (AI) and robotics-driven drug discovery, announced a strategic partnership with a pro...

June 12, 2026 | News

China Clears Adcentrx’s ADRX 0405 For Clinical Development In Advanced Solid Tumours

Follows initiation of Phase 1a/1b study in the U.S. Adcentrx intends to include clinical centers in China to broaden geographic repr...

June 10, 2026 | News

Waters Launches Industry First RP Column Platform To Accelerate GLP 1 And LNP Drug Development

Faster run times for GLP-1, insulin, and LNP drug substance testing accelerates biopharmaceutical development timelines and reduces production bottleneck...

June 10, 2026 | News

MEDIPOST Secures FDA Agreement for Single Pivotal Phase 3 Study of CARTISTEM

MEDIPOST, a fully integrated commercial stage cell therapy biotechnology company, announced today that it has secured the FDA's agreement to conduct a sing...

June 05, 2026 | News

CAS Brings Trusted Scientific Intelligence Directly Into R&D Workflows Through New Connections Framework

CAS, a division of the American Chemical Society specializing in scientific knowledge management, announced CAS Connections, a new integration framework th...

June 05, 2026 | News

Waters Introduces Cyclic IMS P20 to Advance Structural and Spatial Omics Research

Waters Corporation has introduced the Cyclic IMS P20 Mass Spectrometer, a next generation structural and spatial omics platform designed to provide researc...

June 04, 2026 | News

Ginkgo Datapoints, Tangible Scientific and Inductive Bio Launch ADME One to Accelerate Early Drug Discovery

Ginkgo Datapoints, Tangible Scientific, and Inductive Bio Launch ADME-One™: a High-Throughput ADME Platform That Brings Pharmacokinetic Projec...

June 03, 2026 | News

Stay Connected